Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 18
1995 46
1996 49
1997 91
1998 63
1999 66
2000 79
2001 62
2002 65
2003 71
2004 84
2005 90
2006 118
2007 140
2008 154
2009 186
2010 204
2011 267
2012 210
2013 229
2014 221
2015 178
2016 171
2017 206
2018 239
2019 244
2020 51
Text availability
Article attribute
Article type
Publication date

Search Results

2,917 results
Results by year
Filters applied: . Clear all
Page 1
Biological basis for functional cure of chronic hepatitis B
Martinez MG, et al. J Viral Hepat 2019 - Review. PMID 30803126
Current antiviral therapies include nucleoside analogs (NAs) that target the viral retrotranscriptase inhibiting de novo viral production. Pegylated interferon (Peg-IFN) is also effective in reducing the viral DNA load in serum. However, both treatments remain limited to control the infection, aiming for viral suppression and improving the quality of life of the infected patients. ...
Current antiviral therapies include nucleoside analogs (NAs) that target the viral retrotranscriptase inhibiting de novo viral
New treatment options for delta virus: Is a cure in sight?
Yurdaydin C. J Viral Hepat 2019 - Review. PMID 30771261
Current treatment of chronic hepatitis D viral infection with interferons is poorly tolerated and effective only in a minority of patients. Despite delta virus causing the most severe form of chronic viral hepatitis, no other treatments are available. After many years of inactivity, there is now hope for new treatment approaches for delta virus and some are likely to enter clinical practice in the near future. ...
Current treatment of chronic hepatitis D viral infection with interferons is poorly tolerated and effective only in a minority of pat …
Corrigendum
[No authors listed] J Viral Hepat 2019. PMID 31006962
Natural history of serum HBV-RNA in chronic HBV infection
Wang J, et al. J Viral Hepat 2018. PMID 29633430
Virus-like particles encapsulating HBV-RNA represent a serum biomarker for assessing viral replication activity in clinical practice. ...These findings shed light on the nature of viral replication and pathogenesis of disease among different phases of chronic HBV infection....
Virus-like particles encapsulating HBV-RNA represent a serum biomarker for assessing viral replication activity in clinical practice. …
2,917 results
Jump to page
Feedback